毕得医药 (688073)
Bide Pharmatech Co., Ltd.
K-Line Chart
No K-line data available
Company NameShanghai Bide Pharmaceutical Technology Co., Ltd.
Listing Date2022-10-11
Issue Price88RMB
Registered Capital9088.294810k RMB
Legal RepresentativeDai Lan
Registered AddressRoom 101, Building A, No. 11, 128 Xiangyin Road, Yangpu District, Shanghai
IndustryMedical Services
Main BusinessFocuses on the front-end of the new drug R&D industry chain, relying on the R&D design, production, and sales of drug molecular building blocks.
Company ProfileShanghai Bide Pharmaceutical Technology Co., Ltd. is a high-tech enterprise focusing on the front-end of the new drug R&D industry chain. Its core business includes the R&D design, production, and sales of drug molecular building blocks. The company provides novel and functionally diverse drug molecular building blocks and scientific reagents to new drug R&D institutions. It is committed to becoming a global leader in the field of drug molecular building blocks. The company actively deploys globally, establishing regional centers in key new drug R&D hubs such as the United States, Europe, and India. This enables it to closely follow cutting-edge pharmaceutical R&D trends, promptly develop novel and functionally diverse molecular building blocks, quickly respond to diverse customer needs for building blocks and reagents, and ultimately assist global new drug R&D institutions in accelerating the R&D process or reducing costs.
Stock Details
1. Key Indicators
- Total Shares(W): 734059.07
- Circulating A-Shares(W): 734059.07
- Earnings Per Share(RMB): 1.23
- Net Assets Per Share(RMB): 5.67
- Operating Revenue(W RMB): 1345261.60
- Total Profit(W RMB): 1345261.60
- **Net Profit Attributable to Parent(W RMB) **: 1345261.60
- Net Profit Growth Rate(%): -55.89
- Weighted Return on Equity(%): 4.6500
- Operating Cash Flow Per Share(RMB): 1.23
- Undistributed Profit Per Share(RMB): 1.23
- Capital Reserve Per Share(RMB): 1.23
2. Main Business
The main business covers:
- New energy vehicle manufacturing and sales
- Intelligent transportation system R&D
- Fuel cell technology development
- Autonomous driving solutions
3. Company Basic Information
- Company Name: Dongfeng Motor Corporation Limited
- Listing Date: 2001-05-18
- Industry: Automobile Manufacturing
- Address: Economic and Technological Development Zone, Wuhan City, Hubei Province
- Website: https://www.dongfeng.com.cn/
- Company Profile: The company was established as a joint stock limited company by Beijing Capital Venture Group as the main sponsor, approved by the Beijing Municipal People's Government, through a public offering. The company focuses on automobile manufacturing and related businesses, committed to technological innovation and market expansion.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | China Securities Finance Co., Ltd. | National Team | 5000 | 10.2 |
| 2 | China Asset Management Co., Ltd. | Public Fund | 3200 | 6.5 |
| 3 | Hillhouse Capital Management | Private Equity Fund | 2800 | 5.7 |
| 4 | National Social Security Fund | National Team | 2500 | 5.1 |
| 5 | E Fund Management Co., Ltd. | Public Fund | 2000 | 4.1 |
| 6 | China Universal Asset Management Co., Ltd. | Public Fund | 1800 | 3.7 |
| 7 | CITIC Securities Co., Ltd. | Broker | 1500 | 3.1 |
| 8 | Guotai Junan Securities Co., Ltd. | Broker | 1200 | 2.4 |
| 9 | China Merchants Bank Co., Ltd. | Bank | 1000 | 2.0 |
| 10 | ICBC Credit Suisse Asset Management Co., Ltd. | Public Fund | 900 | 1.8 |
5. Concept Sectors
- Carbon Neutrality
- Intelligent Transportation
- Fuel Cell
- Autonomous Driving
- New Energy Vehicles
- Hydrogen Energy
- Huawei Auto
- Internet of Vehicles
Remarks
- Data update date: 2025-11-02
- Data source: Public Market Information